In patients with low-grade non-muscle- invasive urothelial carcinomas, IMP3 expression also proved to be an unfavorable prognostic factor of tumor recurrence (Fig. 4a: P = .025) and progression (Fig. 4b: P = .049). The gene discussed is IMP3; the disease is neoplasm.